Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Covega Corporation was a leading developer of advanced Indium Phosphide (InP) and Gallium Arsenide (GaAs) based optical components and gain media. The company specialized in high-performance Superluminescent Light Emitting Diodes (SLEDs) and Gain Chips, which became critical components for Optical Coherence Tomography (OCT) systems used in medical imaging. These technologies are widely utilized in ophthalmology for retinal imaging and in cardiology for intravascular diagnostics. Covega was acquired by Thorlabs in 2009, and its technology continues to serve as a foundation for Thorlabs' medical imaging and fiber-optic product lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on COVEGA.